GlassScriptPhysician profile
Cary D Brown
NPI 1992700629
$1,474.14
in general payments reported to CMS, 2019-2025
13 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $213 · 2021: $84.45 · 2022: $50.08 · 2023: $103 · 2024: $332 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413 · Long Term Medical Supply Or Device Loan: $291 · Travel and Lodging: $21.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.21 |
| Long Term Medical Supply Or Device Loan | $290.61 |
| Travel and Lodging | $21.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $466.61 | 2020-2025 | Integra, Cytal, Primatrix |
| Smith+Nephew, INC. | $371.97 | 2019-2024 | Collagenase Santyl |
| Kerecis Limited | $233.62 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Misonix INC | $101.89 | 2019-2021 | |
| Kci USA, INC. | $74.49 | 2019-2020 | |
| Solventum Corporation | $71.22 | 2024 | Activ.A.C. |
| Reapplix INC. | $40.52 | 2023 | 3c Patch Kit - Box |
| Convatec INC. | $28.51 | 2022 | |
| Bioventus LLC | $21.57 | 2022 | |
| Organogenesis INC. | $19.97 | 2019 | |
| Medline Industries LP | $18.46 | 2019 | |
| Normatec Industries, LP | $12.82 | 2019 | |
| Tactile Systems Technology INC | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cary Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.